Nanobiology, involving activities at the 1-100 nm size level, has become a key foundation of contemporary biomedical advancement, allowing interaction with the biological system at unprecedented precision compared to previously existing methods. In this review paper, we explore the current status of this field by considering the transition from empirical formulations to mechanisms and AI-based design processes. Important recent developments include stimuli-sensitive "smart" nanocarriers capable of payload release upon exposure to particular pathological conditions, such as pH changes, redox environment, and enzyme activity, and therapeutic diagnostic or theranostic nanoconstructs providing real-time diagnosis and targeted treatment. The article highlights the revolutionary role of nanotechnologies in multiple medical fields and describes examples like the use of lipid nanoparticles (LNPs) as mRNA vaccine delivery vehicles, application of spherical nucleic acids (SNAs) targeting specific organelles and the blood-brain barrier (BBB), and incorporation of biomimetic scaffolding structures into regenerative medicine. However, despite the promising progress made within the field, an enormous "implementation gap" between basic research and its translation into practice exists and is mainly caused by problems such as difficult host immunogenicity responses, chronic nanotoxicity, and uncontrolled protein corona effects. In conclusion, we provide a forward-looking strategy for the discipline that emphasizes the adoption of sustainable "green" chemistry principles and the integration of machine learning and artificial intelligence to optimize structure-property interactions. Nanobiology is positioned to provide responsible, individualized, and high-impact therapeutic solutions for the world’s most difficult diseases by addressing current knowledge gaps in nano-bio interactions and improving translational pipelines.
22 October 2024 in International Journal of Applied and Experimental Biology
Calotropis procera has the potential as a traditional medicinal plant that offers a diverse array of healing treatments. It was used in conventional medicine to remedy several ailments, including diarrhea and snakebites. This study examines the antibacterial properties of silver nanoparticles derived from the floral and latex components of C. procera. The nanoparticles were tested for their effectiveness against Gram-negative and Gram-positive bacterial strains. For characterization, the synthesized nanoparticles underwent thorough analysis using UV spectroscopy, fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and scanning electron microscopy (SEM). After the reduction process, the FTIR analysis revealed that some functional biomolecules found in plants form a coating on the nanoparticles, serving as organic agents that stabilize the nanoparticles. The size of nanoparticles analyzed with SEM falls in the 30 to 130 nm range. Furthermore, the synthesized silver nanoparticles were tested as antimicrobial agents against Escherichia coli, Bacillus subtilis, Staphylococcus aureus, and Pseudomonas aeruginosa, well-known microorganisms that can produce ulceration phases and severe health consequences. After a comprehensive examination, it was found that the silver nanoparticles have significant antibacterial effectiveness, particularly against S. aureus, a primary bacterium responsible for causing different ailments. The remarkable antibacterial efficacy of the silver nanoparticles synthesized in an environment-friendly manner underscores its potential applications in combating the evolution of antibiotic-resistant strains.